Author

Terrance Ku

Observed names: Ku, Terrance, T. Ku, T.J. Ku, Terrance J.Y. Ku

Institutions: University Health Network, University of Toronto

Observed institutions: University Health Network, University of Toronto

ORCID: 0000-0002-6757-3757

Observed ORCID: 0000-0002-6757-3757

OpenAlex ID: A5029664874

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients

2021 · Victoria G. Hall, Victor H. Ferreira, et al. · New England Journal of Medicine · 534

PDF

Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients

2021 · Victoria G. Hall, Victor H. Ferreira, et al. · American Journal of Transplantation · 156

Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients

2021 · Arnaud G. L'Huillier, Cedric Hirzel, et al. · Transplantation · 53

T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients

2020 · Arnaud G. L’Huillier, Victor H. Ferreira, et al. · Scientific Reports · 38

PDF

Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients

2019 · Arnaud G. L’Huillier, Victor H. Ferreira, et al. · American Journal of Transplantation · 37

Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin

2021 · Rafaela V.P. Ribeiro, Terrance Ku, et al. · The Journal of Heart and Lung Transplantation · 33

Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation

2020 · Terrance J.Y. Ku, Rafaela V.P. Ribeiro, et al. · EBioMedicine · 29

PDF

Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients

2021 · Cedric Hirzel, Arnaud G. L’Huillier, et al. · American Journal of Transplantation · 28

PDF

Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients

2021 · Tina Marinelli, Victor H. Ferreira, et al. · Transplantation · 25

Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response

2021 · Ashley Di Meo, Jessica J Miller, et al. · The Journal of Applied Laboratory Medicine · 22

PDF

Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients

2021 · Victor H Ferreira, Tina Marinelli, et al. · The Journal of Infectious Diseases · 18

Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial

2019 · Arnaud G L’huillier, Victor H Ferreira, et al. · The Journal of Infectious Diseases · 13

Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion

2020 · R. VP Ribeiro, T. Ku, et al. · The Journal of Heart and Lung Transplantation · 5

Ex-Vivo Lung Perfusion Mediated Delivery of Rituximab to Clear Latent Epstein-Barr Virus

2019 · T.J. Ku, M. Cypel, et al. · The Journal of Heart and Lung Transplantation · 1

Treatment of Cytomegalovirus in Human Donor Lungs with a Novel Chemokine-Based Immunotoxin during Ex Vivo Lung Perfusion Prevents Viral Reactivation

2021 · R. VP Ribeiro, T. Ku, et al. · The Journal of Heart and Lung Transplantation

PDF

Ex-vivo Lung Perfusion Mediated Delivery of Rituximab to Clear Epstein-Barr Virus in Donor Lungs

2019 · Terrance Ku · TSpace (University of Toronto)

PDF

Works count: 19

Citation count: 992

H-index: 12

I10-index: 12